Bioinformatics services market is anticipated to reach USD 4.1 billion by 2024, according to a new report by Grand View Research, Inc

Global bioinformatics services market is anticipated to reach USD 4.1 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of I.T. solutions for different studies such as cell signaling, pathway metabolism, gene-receptor interactions, and target differentiation are expected to support growth in this market over the forecast period.

                      North America bioinformatics services market, By type, 2013 - 2024 (USD Million)

Owing to the benefits associated with the use of informatic solutions for laboratory protocol generation and data management as well as analysis, these solutions are projected to witness substantial demand in the coming years.

Moreover, collaborative activities undertaken by the information technology companies with pharmaceutical companies and clinical research organizations in order to develop and update key technologies linked to cloud computing, like online data storage and visualization of computer resources are expected to enhance market potential through to 2024.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/bioinformatics-services-market

Further key findings from the report suggest:

• NGS is estimated to be the dominant segment with respect to the type of service served in 2015 owing to the fact that sequence-based approach of analysis can be cataloged with the structure-based approach as complementary to genomic and proteomic approaches. Advancement in the sequencing technologies such as NGS and scripting tools (Perl & Python) for sequence manipulation coupled with the reduction in prices of the sequencing platforms and market movement towards the USD 1,000 genome resulted in a larger revenue share of this segment in the discovery informatics.

• Market revenue from of chemoinformatics is second only to NGS and its strong market position can be accounted for by presence of several entities operating in this segment and their involvement in the provision of lead identification, validation, assay development, lead generation, optimization, and clinical trial based informatic solutions.

• Depending on the application, transcriptomics is anticipated to register the fastest growth of over 15% owing to rise in the number of projects carried out in translational research and application of RNA transcripts for studying etiology of chronic as well as acute diseases.

• Academic sector, in terms of end-use for these services, is expected to witness the fastest growth through to 2024 as a result of rise in the adoption rate of these technologies in genomic, proteomic and metabolomics research programs carried out by universities research institutes. If not all, most of these programs are either backed through government funding or private corporation backing and forms a considerable part of the high R&D investment that the bioinformatics market attracts in the current scenario.

• North America dominated the industry in 2015, accounting for a little 35% of total revenue. Presence of key participants operating in the region which are involved in development of novel algorithms and software in order to improve drug attrition rates which consequently increases adoption rate of computational algorithms is attributive for the largest share of North America in sector revenue. Demand for informatic services in Europe is also increasing owing to the presence of universities in Germany and UK that are involved in development of I.T. solutions for pharmaceutical research.

• Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the fact that government and regulatory authorities have implemented a framework to encourage R&D collaborations and framework extension. Active expansion strategies undertaken by a number of the major market entities operating in the American market in order to strengthen their position in Asia Pacific region is a factor anticipated to consequently drive growth.

• Key players operating in this industry include Agilent technologies, Siegen Inc., GVK Biosciences, Accelerys Inc, Illumina Inc., DNAnexus, Life Technologies Corporation, Geneva Bioinformatic, Celera Corporation, IBM Life sciences, and Affymetrix.

• These entities are adopting strategies such as collaborations with pharmaceutical and biotechnology companies in order to enhance industrial presence by providing different data management and analytical services for the purpose of drug design and therapeutic monitoring.

Free sample request:

http://www.grandviewresearch.com/industry-analysis/bioinformatics-services-market/request

Orthopedic devices market is expected to reach USD 43.1 billion by 2024

The global orthopedic devices market is expected to reach USD 43.1 billion by 2024, according to a new report published by Grand View Research, Inc. Major drivers of the market include the rising demand for orthopedic surgeries owing to the growth in road accidents and the prevalence of orthopedic diseases. 

The introduction of new products made of materials, such as various types of ceramics and polymers, has led to a rise in the success rates of surgeries. In addition, these products are available at affordable costs and customizable sizes and shapes. As a result, the adoption of these advanced products is swiftly increasing. In addition, the rising geriatric population prone to orthopedic diseases, such as osteoporosis and arthritis, is augmenting the growth of the market.
                            
                            Japan Orthopedic Devices Market, By Product Type, 2014 - 2024 (USD Million)

Hip and knee applications together accounted for the largest market share in 2015. A relatively high rate of hip and knee replacement surgeries coupled with the constant innovations in the treatment of hip and knee injuries is contributing towards the growth of these application segments. 

Stringent regulatory approval procedures are the prime factors restraining the growth of the market. In addition, a high device cost and expensive surgical costs are some other factors impeding the market growth.

Download free sample request at:

http://www.grandviewresearch.com/industry-analysis/orthopedic-devices-market/request

Further key findings from the study suggest:

• The knee orthopedic devices segment captured the largest share of the market in 2015. This was attributed to the factors such as a high rate of knee surgeries including common knee injuries to total knee replacements.

• The hip orthopedic devices segment was the second largest market in 2015. The large portfolio for hip injury management is expected to result in a significant share in the global market.

• North America captured the largest market share of 51.4% in 2015 and is expected to maintain its dominance over the forecast period. The presence of a large number of major market players and a high adoption rate of advanced technologies are the factors driving the growth of the market in the region.

• The Asia Pacific market is expected to witness a lucrative CAGR of 8.6% during the forecast period. The presence of a large untapped market and the availability of supportive government regulations are expected to attract the attention of the global players.

• Some major players in the orthopedic devices market include NuVasive, Inc., Medtronic PLC, Zimmer-Biomet Holdings, DePuySynthes, Stryker, Aesculap Implant Systems, LLC, Donjoy, Inc., and Conmed Corporation

Grand View Research has segmented the orthopedic devices market on the basis of applications, product type and geography.

Orthopedic Devices, by Application, 2013 – 2024 (USD Million)

• Hip Orthopedic Devices

• Knee Orthopedic Devices

• Spine Orthopedic Devices

• Craniomaxillofacial Orthopedic Devices

• Dental Orthopedic Devices

• Sports Injuries, Extremities and Trauma(SET) Orthopedic Devices

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit at: http://www.grandviewresearch.com

Biosimilars market is anticipated to witness a marked growth during the period of 2016 to 2024

The biosimilars market is expected to reach USD 41.7 billion by 2024, according to a new report by Grand View Research, Inc. The global biosimilars market is anticipated to witness a marked growth during the period of 2016 to 2024. The most significant factor leading to the growth of this industry is the fact that major biological drugs are nearing the patent cliff. Further, the lower cost of these drugs as compared to the patented biologics, the increasing encumbrance to cut down healthcare costs across the medical systems in the world, and the favorable clinical outcomes demonstrated through clinical trials for the biosimilar drugs is expected to boost the industry.

For the purpose of this study, the major countries considered are the U.S., Canada, the UK, Germany, India, China, Brazil, and Russia. It was estimated that in 2015, Europe accounted for the largest market share of the global biosimilars market, followed by Asia Pacific.

The industry is segmented on the basis of type of products and applications. With regard to the product type, the recombinant non-glycosylated segment is projected to flourish rapidly during the study period. On the other hand, the recombinant glycosylated proteins segment is estimated to grow at a significant CAGR during the period 2015 to 2024 due to the increasing, wide spread incidence of cancer cases (24 million by 2035), which is identified as the crucial factor driving the growth of this sector.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/biosimilars-market

Further key findings from the study suggest:

• North America is anticipated to be the fastest growing market during the forecast period. The biosimilars market has gained significant momentum in the U.S., presenting new opportunities for R&D and the manufacturing sector of biosimilars.

• The European market is the most advanced one as it has been the first to formulate a regulatory pathway and adopt the use of biosimilars for more than 8 years now. Germany accounts for the maximum share in the biosimilars industry, followed by the rest of the European countries (UK, France, Spain, and Italy).

• The Asia Pacific market is expected to witness a lucrative growth during the period 2015 to 2024. India and China are the key countries identified that are expected to lead the industry growth in the study period.

• The market for oncology is estimated to soar at a rapid pace in accordance with the increasing incidence of cancer cases in the world. Additionally, the demand for cost-effective cancer treatments is expected to further fuel the industry growth.

• The biosimilars market comprises several local as well as global players. Some major players of this market include Amgen, Inc., Beacon Ltd., Tea Pharmaceutical Industries Ltd., Merck & Co., Milan, Inc., Dr. Reddy’s Laboratories, Inc., Sandoz, Inc., and Celltrion Healthcare Co., Ltd. 

To get free sample request:

http://www.grandviewresearch.com/industry-analysis/biosimilars-market/request

Contraceptive Drugs and Devices Market Growth And Segment Forecasts To 2020

Contraception is more commonly known as fertility and birth control which are described as the methods to avoid pregnancy. These devices and drugs function by changing the mechanism of ovulation or by acting as a physical barrier between the sperm and ovum. Lack of contraception results in unwanted pregnancies and abortions which have an impact on healthcare costs.  The provisions, planning and usage of contraceptives is known as family planning. The proper use of contraceptives such as female and male condoms also prevents the spread of sexually transmitted diseases. Family planning includes hormonal, barrier, sterilization and application of intra-uterine devices as methods for birth control. Apart from these there are also behavioral, dual protection and emergency controls available for prevention of pregnancy. The global market for contraceptives encompasses oral, vaginal, injectable contraceptive drugs and male/female contraceptive devices. These products are readily available at outlets ranging from pharmacies and chemists to reproductive health and fertility centers. All of the sexually active females within the childbearing age are at a risk of unwanted pregnancies due to unsafe sexual activity. The rapid rate of global population expansion poses a major cause for concern regarding birth control. This has resulted in an acute interest among the consumers to curb unplanned and unwanted pregnancies. Rising number of government initiatives directed towards curbing these unwanted abortion related expenses is the most significant driver of the global contraceptives market. Moreover, the presence of high contraception related needs of women (according to WHO the prevalence of women with unmet contraception needs was estimated at 200 million in 2011) and the rising global prevalence of sexually transmitted diseases also serves the market as a driver. The market for contraceptives is also influenced by political and social considerations. Owing to the transformations in regional demographics, cultural/sociological changes among nations and the constant rapid increase in the population world over combined with the global economic slowdown, the market for contraceptives is expected to witness a steady growth in demand throughout the forecast period.

Free sample request at:
http://www.grandviewresearch.com/industry-analysis/contraceptive-drugs-and-devices-industry/request

Key product segments analyzed in this study include contraceptive drugs, male contraceptive devices and female contraceptive devices. The highest demand in the market is for contraceptives drugs. With the advancement in technology and development of new emergency oral contraceptive pills are seen as the easiest method of contraception. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. The simplicity of their usage makes them an ideal contraceptive in the market. The other forms of contraceptive drugs such as topical and injectable contraceptives also witness strong market demand. The future growth of the contraceptive drugs and devices market will be fuelled by the introduction of cheap contraceptives such as Sino-Implant (II) and the presence of an extensive contraceptives product pipeline (e.g. male contraceptive drugs, Pill-Plus and AG200-15 Contraceptive Patch). 

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Medical Imaging Systems Market Share, Analysis and Segment Forecasts To 2020

The global market for medical imaging systems is expected to reach USD 37.83 billion by 2020, according to a new study by Grand View Research, Inc. Increasing geriatric population base augmenting the susceptibility of patients towards chronic diseases such as cardiovascular, orthopedic and respiratory diseases coupled with increasing patient awareness levels is expected to drive market growth over the next six years. Some of the other drivers for this market include growing demand for refurbished and retrofitted devices, introduction of digital and portable X-ray systems and increasing adoption rates of PACS in healthcare establishments as a cost effective and technologically advanced alternative.

X-ray equipment dominated the overall market in terms of share in 2013, with market revenue valued at USD 8.1 billion. Increasing demand for home healthcare, reduction in handling and maintenance cost post the introduction of handheld and portable devices are some of the factors accounting for X-ray equipment demand growth. Ultrasound systems followed X-ray in 2013 accounting for a revenue share of over 23% on account of the rising demand for portable and mobile devices.

Further key findings from the study suggest:

• Computed radiography dominated the overall X-ray technology market and was valued at over USD 2.80 billion in 2013. Growing demand for higher quality digital images for effective diagnostic purposes and the increasing demand for PACS implementation are some of the factors expected to drive market growth during the forecast period.

• North America, owing to its sophisticated healthcare infrastructure, reimbursement framework and high healthcare expenditures dominated the market in 2013, accounting for over 32% of global revenue.

• Asia Pacific on the other hand is expected to register the highest CAGR of 7.5% during the forecast period, and is expected to outgrow North America by 2020. The presence of high unmet medical needs coupled with constantly improving healthcare infrastructure and healthcare expenditures in emerging markets such as China and India is expected to boost demand over the next six years. In addition, high demand for retrofitted and refurbished medical imaging systems in these markets is expected to serve as a driver.

• Key players for this market include GE Healthcare, Shimadzu Corporation, Toshiba Medical Systems, Siemens Healthcare and Philips Healthcare.

Free sample request:

http://www.grandviewresearch.com/industry-analysis/medical-imaging-systems-market/request

For the purpose of this study, Grand View Research has segmented the global medical imaging systems market on the basis of product, technology and region:

    • Medical Imaging Systems Technology Outlook

            • X-ray Devices

                    • Stationary

                    • Mobile

                    • Handheld

            • Computed Tomography

                    • Stationary

                    • Portable

            • Ultrasound Systems

                    • Trolley/Cart Based

                    • Compact/Portable

            • Magnetic Resonance Imaging

                    • Closed

                    • Open

            • Nuclear Imaging

    • Medical Imaging Systems Technology Outlook

            • X-ray Devices

                    • Analog

                    • Computed Radiography

                    • Digital Radiography

            • Computed Tomography

                    • Low – slice Scanners

                    • Medium – slice Scanners

                    • High – slice Scanners

            • Ultrasound Systems

                    • 2D

                    • 3D & 4D

                    • Doppler

                    • HIFU

                    • Lithotripsy

            • Magnetic Resonance Imaging

                    • High field

                    • Mid field

                    • Low field

             • Nuclear Imaging

                    • SPECT

                    • PET

    • Medical Imaging Systems Regional Outlook

                • North America

                • Europe

                • Asia Pacific

                • RoW

For  more info visit @ www.grandviewresearch.com

Home Healthcare Market is expected to reach USD 355.3 billion by 2020, growing at an estimated CAGR of 7.8% from 2014 to 2020

The Global Home Healthcare Market is expected to reach USD 355.3 billion by 2020, growing at an estimated CAGR of 7.8% from 2014 to 2020, according to a new study by Grand View Research, Inc. Home healthcare products are generally applied to a broad range of equipment and services designed for exclusive use for home or other non-medical establishments by non-professional caregivers, family members, or the patients themselves. Increasing adoption of telehealth and other emerging healthcare technologies are expected to drive market growth over the forecast period. Home healthcare is rapidly getting adopted as a cost effective alternative to healthcare establishment based therapy and therefore, growing geriatric population base and prevalence of chronic conditions requiring long term care is also expected to have a positive impact on growth. Presence of untapped potential in emerging markets such as India, Brazil and China and increasing health awareness are expected to serve this market as future growth opportunities.

                              Global home healthcare market, by services, 2012 - 2020 (USD million)

Further key findings from the study suggest:

• Home healthcare services dominated the overall market, accounting for over 85% of global revenue in 2013, due to increasing demand for Infusion therapy services and telemetry.

• Infusion therapy is expected to be the fastest growing services market, at an estimated CAGR of 11.7% from 2014 to 2020. Increasing initiatives undertaken by healthcare service providers to curb costs associated with specialty drugs and by retail pharmacies to render efficient chronic disease management solutions are some of the drivers of this market.

• Home healthcare based diagnostics dominated the product market in terms of share at 41.4% in 2013. Growing prevalence diabetes and cardiovascular diseases and the consequent rise in demand for constant patient monitoring is one of the major factors attributing to its large share.

• North America was the largest regional market in 2013, accounting for over 40% of the revenue. Presence of sophisticated healthcare and reimbursement infrastructure, high patient awareness levels and healthcare expenditure are some of the factors accounting for its large share. In addition, increasing R&D initiatives aimed at developing new products suitable for use in home healthcare environments is expected to boost market demand in this region.

• Asia Pacific home healthcare market is expected to grow at the fastest CAGR of 9.7% from 2014 to 2020 majorly owing to high unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging markets of India and China. Presence of a large geriatric population base in Japan is also expected to drive regional market growth during the forecast period.

• Key industry participants of this market include Almost Family Inc., B. Braun Melsungen AG, Abbott Laboratories, Sunrise Medical Inc., 3M healthcare, Baxter international Inc., Medtronic Inc., Cardinal health Inc., Roche diagnostics corp., Air liquid, Arcadia resources, Inc., Bayer healthcare AG, Amedisys, Inc., Nxstage Medical, Inc., Arkray Inc., Apria healthcare group, Odyssey Healthcare Inc., Medline Industries Inc., Philips healthcare, Medco Health Solutions Inc., Graham-Field health products Inc., Hill-Rom holdings Inc., Gentiva health services Inc., Johnson & Johnson, Linde Healthcare, Lincare holdings Inc. and Kinetic concepts .

Download free sample request:

http://www.grandviewresearch.com/industry-analysis/home-healthcare-industry/request

For the purpose of this study, Grand View Research has segmented the home healthcare market on the basis of product, services and region:

    • Home Healthcare Product Outlook

            • Therapeutic equipment

                    • Home respiratory therapy equipment

                    • Home insulin delivery devices

                    • Home IV pumps

                    • Other therapeutic equipment

                    • Home dialysis equipment

            • Home diagnostic equipment

                    • Home diabetes care devices

                    • Home blood pressure monitors

                    • Home multi-parameter patient monitors

                    • Home pregnancy and fertility tests

                    • Other self monitoring equipment

                    • Apnea and sleep monitors

                    • Holter monitors

                    • Heart rate meters

            • Mobility assist and other equipment

                    • Wheelchairs and related devices

                    • Home medical furniture

                    • Walking assist devices

    • Home Healthcare Service Outlook

            • Rehabilitation service providers

            • Unskilled home care 

            • Respiratory therapy services

            • Infusion therapy

            • Telemetry

    • Home Healthcare Regional Outlook 

            • North America

            • Europe

            • Asia Pacific

            • RoW

For more information visit at: www.grandviewresearch.com

Artificial organ and bionics market is expected to reach USD 38.75 billion by 2020 at an estimated CAGR of 9.3% from 2014 to 2020

The global market for artificial organ and bionics is expected to reach USD 38.75 billion by 2020 at an estimated CAGR of 9.3% from 2014 to 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of acute renal failure and renal disorders due to lifestyle habits such as excessive alcohol consumption and growing geriatric population base causing a rise in organ failure rates is expected to serve this market as a high impact rendering driver. In addition, growing incidence rates of accidents is expected to boost the demand for organ transplants, thus increasing demand for artificial organ. Artificial kidney dominated the global market in 2013, with revenue estimated at over USD 12.21 billion; demand is expected grow due to the increasing chronic kidney patients. Artificial liver is the fastest growing market segment, at an estimated CAGR of 11.0% from 2014 to 2020.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/artificial-organ-and-bionics

Further key findings from the study suggest:

• Brain bionics in the medical bionics market held the largest share of revenue for the year 2013 and the market is expected to grow at an estimated CAGR of 40.0%.The presence of high unmet medical needs in neurology disease segment coupled with expensive treatment procedures is expected to drive the market for brain bionics. Exoskeleton is the fastest growing segment and is expected to grow at a CAGR of 16.0% from 2014 to 2020.
• North America was the largest regional market in 2013, accounting for over 42.0% of global revenue due to the increasing population and awareness among the patients and the players.
• Asia Pacific is the fastest growing market and is expected to grow at a CAGR of 11.0% from 2014 to 2020 on account of rising demand due to the improvement in healthcare facilities, medical tourism and others.Increasing income levels and healthcare expenditure is expected to interest of the players’ in the emerging markets.
• Key industry participants include Abiomed Inc., Asahi Kasei Kuraray Medical Co. Ltd., Thoratec Corporation, WorldHeart Corp., Gambro AB and others.

For the purpose of this study, Grand View Research has segmented the global artificial organ and bionics market on the basis of product, technology and region:

    • Artificial Organ Product Outlook

            • Artificial organs

                    • Total artificial heart

                    • Artificial liver

                    • Artificial pancreas

                    • Artificial lungs

                    • Artificial kidney

            • Bionics

                    • Cochlear implants

                    • Exoskeletons

                    • Cardiac bionics

                            • Heart valves

                            • Biological tissue valves

                            • Mechanical valves

                            • Transcatheter heart valves

                    • Ventricular assist device

            • Bionic limbs

                    • Bionic legs

                    • Bionic hands

            • Brain bionics

                    • Deep brain stimulators

                    • Spinal cord stimulators

                    • Vagus nerves stimulators

            • Vision bionics

    • Artificial Organ Technology Outlook

            • Mechanical bionics

            • Electronic bionics

    • Artificial Organ Regional Outlook

            • North America

            • Europe

            • Asia Pacific

            • RoW

Download free sample request:

http://www.grandviewresearch.com/industry-analysis/artificial-organ-and-bionics/request

Endocrine Testing Market Growth, Share And Segment Forecasts To 2024

The global endocrine testing market is expected to reach USD 13.0 billion by 2024, according to a new report by Grand View Research, Inc.The growing geriatric population and persisting cases of illnesses, such as diabetes and obesity, are estimated to drive the market.

The target population for this industry is geriatric patients as they are highly prone to various chronic disorders. They have decreased immunity, are prone to age-related deformities, and are at a higher risk of developing complications. As per the WHO statistics on geriatric population, there would be a two-fold rise in the geriatric population; for example, in the U.S. by 2050, geriatric patient count of age 65 and above would be 83.7 million as compared to 43.1 million in 2012.

          North America endocrine testing market share, by technology, 2013 - 2024 (USD Million)

Sedentary lifestyles of people with unhealthy food habits, and increasing stress levels resulted in an increase in the diabetic and obese population. This demographic is highly susceptible to endocrine diseases and is anticipated to contribute to industry growth substantially.

Technological advancements in terms of accuracy and affordability resulted in an increased usage of these tests. For instance, the influx of test kits, for home-based testing has fostered the demand for these techniques, helping the market to grow.

Complete report is available at:

http://www.grandviewresearch.com/industry-analysis/endocrine-testing-market

Further key findings from the study suggest:

• The thyroid stimulating hormone test segment held a lucrative share of over 25.0% in 2015 among test type segments.The increasing cases of hyperthyroidism and hypothyroidism are anticipated to contribute to the growth.

• In the technology segment, the immunoassay technology segment shared the highest market share owing to the increased analysis of hormonal levels using Radioimmunoassay(RIA) and enzyme-linked assays

• The commercial laboratories in the end-use segment exhibited remunerative growth in 2015 and this can be attributed to the presence of sophisticated work environment, which yields faster and accurate diagnosis. Moreover, the dominance of private healthcare sector in developing nations contributed to the growth. For instance, in India, approximately 87.0% healthcare is privately financed. In 20 developing countries, their 40-70% GDP is utilized for out-of-pocket expenses in healthcare.

• On the other hand, the home-based test segment is anticipated to witness a lucrative growth over the forecast period. Convenience and affordability of home-based testing are anticipated to contribute to the growth. Additionally, as per the U.S. Bureau of Labor Statistics, since easy-to-use diagnostic kits have been introduced the rank of home-based tests is expected to increase, which in turn isfurther expected to support the lucrative growth rate.

• North America dominated the overall market with a revenue share of over 38.0% in 2015, owing to the presence of well-developed hospitals, reimbursement network, government funding, and the increasing health awareness among people

• However, Asia Pacific is anticipated to be the fastest growing region with a CAGR of about 9.0% over the forecast period.Economic developments and the advancing healthcare system with the aid of supportive government initiatives are anticipated to assist the growth.

• Key players of the industry include Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, bioMérieuxSA, Bio-Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., LabCorp, and Quest Technology.

• Most of these companies have been in the business for over a decade and are bringing in expertise and technological advancements that are helping them sustain themselves in the competition.

Free sample request:

http://www.grandviewresearch.com/industry-analysis/endocrine-testing-market/request

Market for healthcare nanotechnology is expected to reach USD 196.02 billion by 2020 growing at a CAGR of 12.1%, according to a new study by Grand View Research, Inc

The global market for healthcare nanotechnology is expected to reach USD 196.02 billion by 2020 growing at a CAGR of 12.1%, according to a new study by Grand View Research, Inc. Increasing susceptibility of patients towards chronic diseases such as cardiovascular, neurological, oncology and respiratory diseases coupled with increasing R&D spending opening new application avenues is expected to drive market growth over the next six years. Other drivers of this market include increasing government and private sector R&D aid and new players entering the market to bridge the gap between supply and demand.

Clinical oncology nanotechnology applications dominated the overall market in 2013, accounting for 35% of total market revenue. Higher efficacy of nanomaterials and the ability of engineered nanoparticles to cross through the blood brain barrier provides platform for groundbreaking innovations through R&D in the field of cancer therapy and serves this market as a high impact rendering driver.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/healthcare-nanotechology

Further key findings from the study suggest:

• North America was the largest regional market in 2013, accounting for over 38% of global revenue on account of the extensive investments in research and development of innovative cancer therapies.
• Asia Pacific owing to its improving healthcare infrastructure and healthcare R&D spending is expected to grow at the highest CAGR of over 14.0% from 2014 to 2020. Moreover, emerging markets such as China and India hold a large amount of untapped opportunities and are therefore expected to fuel future market growth.
• Cardiovascular applications are expected to be the fastest growing segment for this market, owing to the growing global prevalence of cardiovascular diseases.

For the purpose of this study, Grand View Research has segmented the global healthcare nanotechnology market on the basis of fields of application and region:

    • Healthcare Nanotechnology Application Outlook

            • Drug delivery Systems

            • Molecular Diagnostics

            • Clinical Oncology

            • Clinical Neurology

            • Clinical Cardiology

            • Anti-inflammatory and Anti-infective applications

    • Healthcare Nanotechnology Regional Outlook

            • North America

            • Europe

            • Asia Pacific

            • RoW

Download free sample request:

http://www.grandviewresearch.com/industry-analysis/healthcare-nanotechology/request

Increasing demand for accuracy and reproducibility required during medical procedures is the high impact rendering driver for the medical automation market

The global medical automation market is expected to reach USD 79.4 billion by 2024, according to a new report by Grand View Research, Inc. The increasing demand for accuracy and reproducibility required during medical procedures is the high impact rendering driver for the medical automation market. 

The rising adoption of these devices is attributed to the advantages associated with automated systems. For example, the automation of tedious tasks such as sampling, monitoring of quality, quantity, packaging and labeling, and scanning of medicines and devices, have reduced human efforts and increased speed and accuracy, which has led to increased dependency on these automated systems.

         North America medical automation market share, by application, 2014-2024 (USD Million)

Moreover, the growing global prevalence of chronic conditions such as diabetes, cancer, arthritis, and chronic obstructive pulmonary disease (COPD) is further pushing the demand for therapeutic, laboratory and pharmacy automated medication systems, which are faster and more productive. As per the World Health Organization (WHO) estimates, cardiovascular diseases (CVDs) is the leading cause of mortality around the globe; in addition, an exponential rise has been witnessed in the diabetes cases from 108 million in 1980 to 422 million in 2014. The aforementioned factors are responsible for creating the need for automated medical equipments over the forecast period. 

Furthermore, with the advent of technologically advanced defibrillators and ablation therapies, this market is expected to gain swift growth in its market share in the near future. For instance, automation in the following pharmacy-based functions, medication dispensing, storage, and retrieval enables traceability and tracking, which in turn improves patient safety and reduces errors. Furthermore, there is an increased focus on incorporating automation in hospitals due to the associated benefits, such as reduction of errors and operational costs; these factors altogether are expected to present this market with high growth opportunities in the near future.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/medical-automation-market

Further key findings from the study suggest:

• The therapeutic segment was observed to dominate in terms of revenue share in 2015owing to the high usage rate of automated devices in the non-surgical procedures, such as external defibrillators, an implantable cardioverter, and wearable/ implantable drug pumps 

• On the other hand, the medical logistics and training segment is expected to grow at a lucrative CAGR of over 10.0%. The rising adoption of advanced systems, such as Pneumatic Tube Systems (PTS) used in material transportation and Real Time Location System (RTLS) in location-tracking, contributes towards the overall medical automation market growth during the forecast period. 

• The research laboratories and institutes segment is also identified as a lucrative segment due to, the rising demand for automated research laboratories that are helpful in the detection and the treatment of chronic diseases. These laboratory automated systems help in reducing demand and supply gaps by mechanization, which yields rapid results and increases overall productivity. This is expected to further enhance its usage over the forecast period. 

• With an aim to address the increasing demand for advanced molecular diagnostic techniques in cancer, the Leiden University Medical Center have recently succeeded in isolating DNA and RNA from small tissue samples using a high-throughput, fully automated solution by Siemens. Innovations like these are expected to present the market with significant growth opportunities. 

• Some key players in this industry include Accuray, Inc., Tecan Group Ltd., Medtronic Plc., Swisslog Holding AG, GE Healthcare, Intuitive Surgical, Inc., Stryker Corporation, Siemens AG, Koninklijke Philips N.V., and Danaher Corporation. 

• These industry players are adopting strategies such as technological innovation, new product launches, and strategic collaborations including mergers and acquisitions to capitalize untapped opportunities. For instance, in July 2015, Medtronic Plc. acquired RF Surgical Systems, Inc., for further expansion of its business and with the aim of capturing a huge market share of the medical automation market in the coming years. 

To get free sample request:

http://www.grandviewresearch.com/industry-analysis/medical-automation-market/request

Chemoinformatics market is expected to reach over USD 21.18 billion by 2024 according to a new report published by Grand View Research

The global chemoinformatics market is expected to reach over USD 21.18 billion by 2024 according to a new report published by Grand View Research, Inc. Some major determinants influencing the market growth include the constantly improving modern drug development processes, increasing use of in-silico techniques in research, and the advantages associated with employing the chemoinformatics approach, such as the reduction in the overall R&D expenditure during the drug development process.

The ever increasing growth of the drug development market will boost the demand for chemoinformatics owing to its numerous applications in drug designing at various stages. Right from target identification to its development as a potential drug candidate, chemoinformatics tools play a crucial part.

              North America Chemoinformatics Market, by Application, 2013 - 2024 (USD Billion)

The significant contributions of the varying in silico tools in the generation of hits through the High Throughput Screening(HTS) process, target compound selection, virtual structure generation, Pharmacokinetic property and toxicity prediction of chemical compounds, and the quantitative-structure relationship determination have been a major driving force for the growth of the chemoinformatics market.

The heavy costs incurred along with the long time span invested in the drug discovery process has made the integration of the chemoinformatics techniques essential in the research activities. It aids the scientists and chemical researchers in making better decisions pertaining to drug discovery and other related research studies. Furthermore, the increasing demand for efficient and effective medicines, rising investments in R&D, growing geriatric population, and the burgeoning number of individuals with lifestyle related diseases are expected to positively reinforce the market growth. The key applications of the chemoinformatics tools and softwares in drug designing and discovery has been its largest application and is expected to grow further with further advances in the drug discovery process.

Chemoinformatics has made marked contributions to the areas of chemical drug development and research. The growth of this field is driven by the continually generated raw data in screening operations and research studies. Chemoinformatics in silico tools aid in effective data management, which facilitate data retrieval and analysis thus providing large databases of accessible information to scientists involved in both, the drug development process and other research related studies.

The development of three dimensional chemical structure databases has been a significant achievement in the field of chemoinformatics as it has significantly aided the research process. Applications of chemoinformatics platforms in computer-assisted synthesis designing, computer-assisted structure elucidation, and chemometrics have further contributed to the market growth.

The advancements in computational technology have been a high impact rendering driver for the market growth. In this direction, the development of super computers and silicon graphics computer for calculations, 3D structure generation, molecular graphics, and complex data display have been pivotal in propelling the growth of the chemoinformatics market. With the advent of advanced WEB technologies and their incorporation in the in-silico computational techniques have totally revolutionized this field.

The increasing needs for advanced and efficient technologies to yield better results has made the chemoinformatics area an indispensable part of the pharmaceutical industry. The surging need for therapeutically-effective medicines coupled with the increasing investments in the R&D area and the advancements in computer technologies provide lucrative opportunities to the market for it to grow and flourish in the near future.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/chemoinformatics-market

Further key findings from the study suggest:

• In 2015, North America dominated the chemoinformatics market with a revenue share of over 36% on account of the following factors:  the high investments pertaining to the R&D initiatives, technological advancements, the presence of major players in the drug manufacturing industry, and the increasing prevalence of lifestyle-related diseases. With respect to the global R&D spending, North America holds the largest share. Also, it holds a major share in the ADME-toxicology market that further spurs the growth of the chemoinformatics market.

• Asia Pacific is identified as one of the fastest growing regional markets, growing at a lucrative CAGR of 18.3% during the forecast period. The growth of this market can be attributed to the growing research activities being conducted in economies, such as India, China, and Singapore. The key advantages associated with undertaking research activities in these countries include the low manufacturing and labor costs and the less stringent regulations, which attract many multinational players to the Asia Pacific region. Additionally, the government initiatives and funds that are deployed to improve the R&D infrastructure will further drive the market growth.

• Key players operating in the market include Agilent Technologies, Inc., BIOVIA (Accelrys), Bio-Rad Laboratories, Inc., CambridgeSoft Corp., ChemAxon, Inc., ACD/Labs, Inc., Schrödinger, LLC, and Chemical Computing Group, Inc. Additionally, the rising demand for in-silico techniques in the research sector is expected to provide new market entrants with profitable opportunities thereby driving the market growth.

Grand View Research has segmented the chemoinformatics market by applications:

Global Chemoinformatics Market, by Application (USD Billion, 2016 - 2024)

• Chemical Analysis

• Drug Discovery

• Drug Validation

• Others

Get free sample request:

http://www.grandviewresearch.com/industry-analysis/chemoinformatics-market/request

Smoking Cessation And Nicotine De-addiction Market Growth, Share And Segment Forecasts To 2024

The global smoking cessation and nicotine de-addiction market is expected to reach over USD 21.8 billion by 2024 according to a new report by Grand View Research, Inc. 

The base of population addicted to smoking is rapidly increasing across the globe. This population subset majorly includes teenagers and the working population. Smoking-related mortality is very high. The increasing desire to quit smoking and the numerous health complications associated with smoking serve as strong incentives for companies to introduce novel smoking cessation products, such as Revolymer, which has introduced the next generation nicotine gums to help smokers quit smoking. The launch of these improved and innovative nicotine replacement therapy products is to serve as a high impact rendering driver for the growth of the smoking cessation and nicotine de-addiction market.

U.S. smoking cessation and nicotine de-addiction market, by product, 2014-2024, (USD Million)

The growing incidence of target diseases such as chronic obstructive pulmonary disease (COPD), asthma, cardiac diseases, and lung cancer, and the increasing awareness pertaining to the hazardous side-effects of smoking are the factors expected to promote market expansion. Educational institutions remain active in organizing various campaigns and programs to spread information about the harmful effects and consequences of smoking so as to increase young population awareness. 

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/smoking-cessation-and-nicotine-de-addiction-products-market

Further key findings from the study suggest:

• Nicotine Replacement Therapy (NRT) dominated the smoking cessation and de-nicotine addiction product market in 2015. Majorly used NRT products include nicotine chewing gums and the transdermal patches. Increased availability and the introduction of the ingestible nicotine products with different flavors are the factors responsible for its large market share.

• The e-cigarette segment is anticipated to grow at a CAGR of19.0% over the forecast period. The major factors responsible for the growth of the E-cigarette market include the introduction of second and third generation e-cigarettes, the availability of various flavored products, the presence of numerous vendors operating and selling e-cigarettes under different brand names.

• North America held a large market share of over 35.0% in 2015 owing to the high awareness levels of nicotine de-addiction products with around 90% of the U.S. population were identified as aware of e-cigarettes in 2015

• Asia Pacific is the fastest growing market. The registration of nicotine de-addiction products and e-cigarettes as well as the strengthening of the company distribution channels in countries, such as China, India, and Australia are expected to support the growth over the forecast period

• Some key players of this market are Pfizer, Inc., Cipla Ltd., Novartis International AG, GlaxoSmithKline plc, Takeda pharmaceutical Company Ltd., McNeil AB, Revolymer plc, Imperial Tobacco Ltd., and VMR products, LLC

• The market players are making slow but steady progress in the e-cigarette market by focusing on the development, commercialization, and distribution of the FDA approved nicotine products. For instance, in 2014, Victory Electronic Cigarettes Corporation acquired Ten Motives Ltd. with an aim to expand their distribution channels and attain wider market coverage.

Download free sample request:

http://www.grandviewresearch.com/industry-analysis/smoking-cessation-and-nicotine-de-addiction-products-market/request

Development of information technology pertaining to health care systems plays an inevitable role in the development of the point of care diagnostics market

The global point of care (PoC) diagnostics market is anticipated to reach USD 20.9 billion by 2024, according to a new report by Grand View Research, Inc. Rise in the R&D funding and research activities amongst the market players in order to introduce novel POC tests and devices for ease of disease detection and monitoring is expected to fuel industrial progress through to 2024.

Moreover, the introduction of favorable regulatory initiatives in order to promote the development and adoption of POC diagnostic tests is anticipated to propel growth in the coming years. Furthermore, advancement of diagnostic laboratories and adaptation of more integrated and automated lab systems are also factors expected to fuel demand for advanced workflow systems and drive the digital pathology and workflow segment through to 2024.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/point-of-care-poc-diagnostics-industry

Further key findings from the report suggest:

• Glucose testing accounted for the largest share in revenue in 2015 owing to the higher prevalence of diabetes. Presence of significant product portfolio pertaining to glucose testing in the market and the presence of a number of major players as wells as local manufacturers from different regions are factors attributive to contribute substantially to the revenue generated.

• Hb1Ac POC tests are more reliable for glucose testing and due to the vast patient base for diabetes management, this segment is second in terms of revenue generation in the POC market only to its counterpart. Owing to the presence of glucose testing segment as a potential market and growing cost effectiveness of Hb1Ac tests, it is expected that over the coming decade it will witness considerable growth in demand and usage 

• POC tests for infectious disease testing, is another segment of prime activity in the point of care industry. This segment includes rapid diagnostic tests for a considerable number of diseases including HIV, HBV, RSV, HPV, Influenza, HCV, MRSA, TB/dr-TB & HSV among others.

• Owing to the growing incidence of a number of infectious diseases, initiatives taken by a number of governments to implement early diagnosis and screening, and development of rapid tests able to distinguish between a wide number of pathogens this segment has been observed to be at the demand receiving end in the industry for the better half of the last decade and is only expected to witness growth in demand.

• Hospitals are estimated to be the dominant end-users for POC diagnosis industry owing to higher penetration of products and comparatively higher usage rate for disease monitoring and diagnosis.

• North America dominated the market in 2015, with over 43% of total revenue. Presence of major entities with widespread distribution network coupled with significant number of research endeavors carried out in the U.S is supportive for the largest share of region. Moreover, point of care diagnostics is a relatively more advanced segment of in vitro diagnostics and owing to the presence of high R&D expenditure, availability of a technologically advanced healthcare infrastructure along with the presence of a number of ongoing government funded research projects are factors accounting for the region’s large share.

• Asia Pacific is projected to witness lucrative growth in the coming years owing to the developments carried out in developing economies herein in order to develop the healthcare infrastructure and reduce the incidence of target diseases.

• Major participants of this market include Roche, Abbott Laboratories, Siemens Healthcare, Danaher Corporation, BioMerieux, Johnson & Johnson, Abaxis Inc., Alere Inc., Qiagen N.V., Spectral Diagnostics, Instrumentation Laboratory, Nova Biomedical, Nipro Diagnostics, Trinity Biotech, and Sekisui.

• Participants are involved in adopting competitive strategies in order to enhance the market presence. These companies are also involved in collaborations with hospitals in order to maintain the market share.

• For instance, in April 2015, Nipro diagnostics participated in an industry event named AMCP (Academy of Managed Care Pharmacy) in support of providing care to the patients with diabetes.

Download free sample request:

http://www.grandviewresearch.com/industry-analysis/point-of-care-poc-diagnostics-industry/request

On the basis of technology the breast imaging market has been segmented into ionizing and non-ionizing technologies

The global breast imaging market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. The increasing incidences of breast cancer coupled with the continual product improvements being launched and the numerous R&D innovation initiatives being undertaken in the field of cancer are expected to collectively boost the growth of the market over the forecast period.

                     North America breast imaging market, by technology, 2013-2024, (USD Million)

In 2012, the WHO estimated that around 53.0% of the global women population (1.8 billion women) is anticipated to suffer from breast cancer over their lifespan. This alarmingly rising rate is expected to be the preliminary driver for this market over the forecast period.

The rising base of the geriatric population is another high impact rendering driver of the breast imaging market. A study by the NCBI (National Center for Biotechnology Information) stated that the incidence of breast cancer is higher in patients above the age group of 45.

Increasing expenditure on R&D coupled with government funding are the other vital factors expected to trigger market growth over the forecast period. In 2013, the National Institute of Health, in the U.S. provided a grant amounting to USD 5.6 billion to conduct research on breast cancer. Digital mammography is one of the technologies gaining popularity as compared to other technologies, which is expected to positively reinforce this market’s growth.

However, the high cost of the existing imaging systems coupled with the stringent regulatory policies governing the approval of new products and marketing are predicted to slowdown growth.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market

Further key findings from the study suggest:

• The 3D tomosynthesis segment is identified as the fastest growing segment. This technology offers enhanced efficiency and higher diagnostic accuracy in comparison to other available technologies, which is expected to aid market growth.

• North America is likely to dominate throughout the forecast period with a revenue share of over 30.0% by 2024.Government initiatives including the precision medicine initiative, started by President Obama in 2015, promotes the development of personalized medicine, which is anticipated to foster market growth.

• Asia Pacific is anticipated to grow at the fastest rate of12.0% over the forecast period. The Increasing number of investments in the healthcare sector coupled with the rising awareness of breast cancer and other associated conditions is anticipated to propel the market growth in this region.

• Some major players of the market are Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc., Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.

• In order to gain a competitive advantage in the market, the key industry players are adhering to mergers, acquisitions and collaborative agreements. For instance, in January 2016, Gamma Medica, Inc. entered into a contract with Alpha Imaging Technology Corp. for the commercialization of its new product, Luma GEM.

To get free sample request:

http://www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market/request

Breath Analyzer Market is highly fragmented with the presence of a large number of local manufacturers competing with the global players

The global Breath Analyzer Market is expected to reach USD 11.3 billion by 2024, according to a new report by Grand View Research, Inc. Major drivers of the market include the demand for breath analyzers arising from the law enforcement agencies as well as other institutions, such as schools, sports, and offices, to minimize alcohol abuse and ensure safety in workplace settings.

                                    China Breath Analyzer Market, By Technology, 2014-2024 (USD Million)

The fuel cell technology has been widely used in professional breath analyzers as it offers accuracy, alcohol specificity, and portability. Moreover, the semiconductor sensor technology offers affordable breath alcohol screening devices that are mostly used by private consumers. Breath analyzers that use infrared spectroscopy are currently limited to the law enforcement agencies owing to their high cost and large device size. 

The growing demand for quick and easy methods for the primary diagnosis of diseases, such as asthma, chronic obstructive pulmonary disease, and cancer is augmenting the growth of the global market. In addition, the rising adoption of breath analyzers in smoking cessation programs to detect carbon monoxide in the exhaled air is augmenting the market growth. 

Uncertainty with regard to the accuracy of the devices, the ambiguous laws about installing these devices in offices, and the high prices attached to infrared spectroscopy are the factors that challenge the growth of the global market. Many of the drug detection devices that identify the presence of drugs in the exhaled breath are still in the developmental phase as the detection technology used will depend on the type of the drug. Hence, this poses some uncertainty for the success of these devices. 

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/breath-analyzer-market

Further key findings from the study suggest:

• In 2015, the fuel cell technology segment accounted for the largest share of the market at31.8%. The dominance of the segment is attributed to the popularity of this technology owing to its accuracy and user-friendly product designs.

• The medical application segment is expected to witness the fastest growth from 2016 to 2024 owing to the rapid development of disease diagnostics, such as breath analyzers for asthma and Chronic Obstructive Pulmonary Diseases (COPD)

• North America captured the largest market share at over half of the total revenue in 2015 and is expected to maintain its dominance throughout the forecast period. The presence of a large number of major market players, strict laws for road traffic safety, and a high adoption rate of the advanced technologies are the factors driving the market growth in this region.

• The Asia Pacific market is expected to grow at a lucrative CAGR of around 32% during the forecast period. The existence of a large untapped market and the growing awareness regarding the commercially available and technically advanced products are some of the major drivers of the market in the region.

• The presence of a large number of local manufacturers in the Asia Pacific region offering low-cost breath analyzers in comparison to other manufacturers based in developed countries is one of the factors expected to propel the exports from this region

• Some key players in the Breath Analyzer Market include Dragerwerk AG & Co. KGaA, Intoximeter, Inc., Alcovisor, Quest products, Inc., Lifeloc Technologies, Akers Biosciences, Inc., MPD, Inc., AK GlobalTech Corp., Alcohol Countermeasure Systems Corp., and EnviteC-Wismar GmbH 

Grand View Research has segmented the Breath Analyzer Market on the basis of product, type, and geography.

Breath Analyzer Market, by Technology, 2013 – 2024 (USD Million)

• Fuel cell Technology

• Semiconductor sensor

• Infrared (IR) Spectroscopy

• Others(FAIM, Mass Spectroscopy, Smart Crystals)

Breath Analyzer Market, by Application, 2013 – 2024 (USD Million)

• Drug Abuse Detection

• Alcohol Detection

• Medical Applications

To get free sample request:

http://www.grandviewresearch.com/industry-analysis/breath-analyzer-market/request

Anesthesia Monitoring Devices Market Analysis, By Product (Advanced Anesthesia Monitors, Basic Anesthesia Monitors ) And Segment Forecasts To 2024

The anesthesia monitoring devices market is expected to reach USD 1.9 billion by 2024, according to a new report by Grand View Research, Inc. The growing geriatric population base and the spiraling number of surgeries are anticipated to boost the market growth. Geriatric patients are the target population for this industry as they are highly prone to various chronic disorders and are at a higher risk of developing complications.

    North America anesthesia monitoring devices market, by product, 2013 - 2024 (USD Million)

The rising awareness amongst the physicians about the various factors that affect patient outcomes, such as the choice of anesthetic drug, the appropriate route of administration, and the right dose of the anesthetic agent, as well as the monitoring of the depth of anesthesia is likely to accelerate the growth of the market during the forecast period.

Technological advancements in terms of accuracy, portability, and affordability have resulted in the increased usage of these monitoring devices. For instance, the introduction of the new generation, microprocessor-based intelligent anesthesia systems with integrated monitors enables monitoring of various parameters along with the precisely-controlled administration of the anesthetic agent.

View summary of this report, click the link below: 

http://www.grandviewresearch.com/industry-analysis/anesthesia-monitoring-devices-market

Further key findings from the study suggest:

• Amongst the product type segments, the advanced anesthesia monitors segment held a lucrative share of over 60.0% in 2015 owing to its durability, reliability, and accuracy. Moreover, these devices monitor various significant parameters such as oxygen saturation level, carbon dioxide level, heart rate, and blood pressure.

• The hospitals in the end-use segment exhibited remunerative growth in 2015; this can be attributed to the presence of advanced diagnostic and therapeutic medical technologies that enables both, faster and accurate diagnosis. Moreover, the availability of these advanced systems coupled with the presence of skilled personnel contributes towards profitable growth of this segment.

• North America dominated the overall market with a revenue share of over 35.0% in 2015 owing to the presence of well-developed health care settings and the presence of a favorable reimbursement network, government funding, and increasing health awareness levels amongst the people.

• However, Asia Pacific is anticipated to be the fastest growing region with a CAGR of about 11.0% over the forecast period. The economic developments and the advancing healthcare system with the aid of supportive government initiatives are collectively anticipated to further assist the growth in this region.

• Some key players operating in the anesthesia monitoring devices market include Masimo Corporation, Infinium Medical, Inc., Medtronic plc, GE Healthcare, Nihon Kohden Corporation, Philips Healthcare, Mindray Medical International Ltd., Drägerwerk AG & Co. KGaA, and Schiller AG. New product development, mergers, and collaborations are some key initiatives taken to sustain themselves in the competition.

• For instance, Masimo Corporation incorporated Oxygen Reverse Index (ORI) which measures the oxygen levels and provides real-time information with regard to the patient’s oxygen reserve in synchronization with the partial pressure of oxygen to prevent hyperoxia conditions (oxygen levels above normal) in patients that are receiving auxiliary oxygen supply whilst undergoing surgery.

Download free sample request:

http://www.grandviewresearch.com/industry-analysis/anesthesia-monitoring-devices-market/request